A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
Doctors have discovered that a new groundbreaking therapy has reversed incurable blood cancers in some patients.A therapy, ...
Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...
The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...
Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data ...
The cell and gene therapy CRO market presents growth opportunities driven by FDA-approved therapies, over 90 global approvals, and 3,500 trials across 16 therapeutic areas, primarily in North America.
Treating our first patient is a proud moment for Abeona and a testament to the tireless resolve of our team,” said Vish ...
Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback